Venetoclax▼ (Venclyxto): Updated recommendations on tumour lysis syndrome (TLS) in CLL patients

Fatal cases of TLS have been observed even in patients receiving lowest dose in dose-titration schedule. Strict adherence to dose titration and TLS risk minimisation measures as outlined in SPC is required for all patients. A patient alert card should be given to each patient.

Source:

Abbvie